| Literature DB >> 34277744 |
Shiqin Yu1, Jinying Zhou2, Kai Yang1, Xiuyu Chen1, Yucong Zheng1, Kankan Zhao3, Jialin Song1, Keshan Ji1, Peng Zhou2, Hongbing Yan2,4, Shihua Zhao1.
Abstract
Objectives: To investigate the correlation of cardiac magnetic resonance (CMR) feature-tracking with conventional CMR parameters in patients with a first anterior ST-segment elevation myocardial infarction (STEMI).Entities:
Keywords: ST-segment elevation myocardial infarction; late gadolinium enhancement; left ventricle; magnetic resonance imaging; strain
Year: 2021 PMID: 34277744 PMCID: PMC8282997 DOI: 10.3389/fcvm.2021.705487
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
Figure 1Study flow chart. STEMI, ST-segment elevation myocardial infarction; CMR, cardiac magnetic resonance.
Baseline characteristics of the study population.
| Age, years | 55 (48–63) | 52 (46–63) | 56 (50–62) | 0.26 |
| Male, | 112 (87) | 71 (84) | 41 (93) | 0.12 |
| Body mass index, kg/m2 | 25.4 (23.8–27.7) | 25.5 (23.8–27.9) | 25.4 (23.2–27.1) | 0.52 |
| Hypertension, | 64 (50) | 44 (52) | 20 (46) | 0.50 |
| Hyperlipidemia, | 93 (72) | 61 (72) | 32 (73) | 0.91 |
| Diabetes mellitus, | 40 (31) | 25 (29) | 15 (34) | 0.59 |
| Smoker, | 92 (71) | 57 (67) | 35 (80) | 0.14 |
| Ischemia time, h | 5.0 (3.0–7.8) | 5.0 (3.0–7.3) | 5.0 (3.0–8.0) | 0.81 |
| TIMI flow pre-PCI, | 0.02 | |||
| 0 | 71 (55) | 54 (63) | 17 (39) | |
| 1 | 10 (8) | 6 (7) | 4 (9) | |
| 2 | 15 (12) | 10 (12) | 5 (11) | |
| 3 | 33 (25) | 15 (18) | 18 (41) | |
| TIMI flow post-PCI, | 1.00 | |||
| 0 | 2 (1) | 1 (1) | 1 (2) | |
| 1 | 0 (0) | 0 (0) | 0 (0) | |
| 2 | 1 (1) | 1 (1) | 0 (0) | |
| 3 | 126 (98) | 83 (98) | 43 (98) | |
| Number of diseased vessels | 0.63 | |||
| 1 | 49 (38) | 32 (38) | 17 (39) | |
| 2 | 47 (36) | 31 (36) | 16 (36) | |
| 3 | 33 (26) | 22 (26) | 11 (25) | |
| Admission creatinine, μmol/L | 74.6 (65.2–85.2) | 74.8 (65.0–86.0) | 73.1 (66.2–84.4) | 0.88 |
| Peak cTnI, ng/mL | 27.0 (9.5–53.3) | 33.5 (18.2–60.1) | 13.5 (6.6–31.6) | 0.001 |
| Time of peak cTnI, h | 20 (14–27) | 21 (15–27) | 19 (12–27) | 0.38 |
| Peak NT-proBNP, pg/mL | 1,364.5 (729.1–2,889.1) | 1,666.1 (915.9–3,215.3) | 914.7 (404.7–2,072.2) | 0.001 |
| Time of peak NT-proBNP, h | 29 (22–42) | 32 (24–49) | 26 (19–32) | 0.004 |
PCI, percutaneous coronary intervention; cTnI, cardiac troponin I; NT-proBNP, N terminal pro B type natriuretic peptide.
CMR parameters of the study population.
| LVEF, % | 51 (42–57) | 45 (38–51) | 60 (56–63) | 63 (59–67) |
| SV, mL | 72.58 ± 17.48 | 68.71 ± 16.56 | 80.05 ± 16.96 | 83.66 ± 15.03 |
| EDV, mL | 150.54 ± 34.13 | 159.10 ± 34.25 | 134.02 ± 27.41 | 132.50 ± 23.62 |
| ESV, mL | 71.9 (57.5–96.3) | 88.4 (71.2–107.0) | 54.8 (43.6–63.9) | 47.4 (41.1–57.3) |
| CO, L/min | 4.70 ± 1.19 | 4.57 ± 1.25 | 4.96 ± 1.00 | 6.02 ± 1.09 |
| LGE, % | 12.04 (5.80–19.82) | 17.14 (9.67–24.14) | 6.38 (1.88–11.60) | – |
| GRS, % | 22.39 ± 6.60 | 19.28 ± 4.95 | 28.39 ± 5.08†‡ | 38.54 ± 9.27 |
| GCS, % | −14.11 ± 3.19 | −12.66 ± 2.64 | −16.91 ± 2.11†‡ | −20.77 ± 2.78 |
| GLS, % | −11.46 ± 2.64 | −10.64 ± 2.50 | −13.06 ± 2.15†‡ | −15.52 ± 2.69 |
CMR, cardiac magnetic resonance; STEMI, ST-segment elevation myocardial infarction; LVEF, left ventricular ejection fraction; SV, stroke volume; EDV, end-diastolic volume; ESV, end-systolic volume; CO, cardiac output; LGE, late gadolinium enhancement; GRS, global radial strain; GCS, global circumferential strain; GLS, global longitudinal strain.
p < 0.05 when compared with the controls between 2 groups (the total STEMI group and the controls).
p < 0.05 when compared with the controls among three groups (the STEMI LVEF <55% group, the STEMI LVEF ≥55% group, and the controls).
p < 0.05 when compared with the STEMI (LVEF <55%) group among three groups (the STEMI LVEF <55% group, the STEMI LVEF ≥55% group, and the controls).
Figure 2Correlation of LGE and global strain. LGE, late gadolinium enhancement; GRS, global radial strain; GCS, global circumferential strain; GLS, global longitudinal strain.
Figure 3Global strains in LGE tertiles. LGE, late gadolinium enhancement; GRS, global radial strain; GCS, global circumferential strain; GLS, global longitudinal strain.
Figure 4Receiver operating characteristic analysis for discriminating segmental late gadolinium enhancement >50%. RS, radial strain; CS, circumferential strain; LS, longitudinal strain.
Figure 5Association between segmental strain and LGE extent. RS, radial strain; CS, circumferential strain; LS, longitudinal strain; LGE, late gadolinium enhancement.
Figure 6Strain in infarcted, adjacent, and remote regions. RS, radial strain; CS, circumferential strain; LS, longitudinal strain. *p < 0.05 vs. infarcted region; †p < 0.05 vs. adjacent region; ‡p < 0.05 vs. remote region.
Inter- and intra-observer variability of CMR feature tracking derived global and regional strain parameters.
| Global | 0.916 | 0.773 to 0.971 | 0.9 | 0.736 to 0.965 |
| Basal | 0.859 | 0.578 to 0.953 | 0.749 | 0.416 to 0.907 |
| Mid | 0.924 | 0.788 to 0.974 | 0.883 | 0.693 to 0.959 |
| Apical | 0.869 | 0.651 to 0.954 | 0.886 | 0.690 to 0.960 |
| Global | 0.913 | 0.764 to 0.970 | 0.856 | 0.607 to 0.950 |
| Basal | 0.905 | 0.741 to 0.967 | 0.885 | 0.692 to 0.960 |
| Mid | 0.929 | 0.808 to 0.975 | 0.884 | 0.612 to 0.963 |
| Apical | 0.902 | 0.732 to 0.966 | 0.834 | 0.577 to 0.941 |
| Global | 0.924 | 0.716 to 0.976 | 0.913 | 0.679 to 0.973 |
| Basal | 0.979 | 0.921 to 0.993 | 0.954 | 0.871 to 0.984 |
| Mid | 0.9 | 0.736 to 0.965 | 0.886 | 0.637 to 0.963 |
| Apical | 0.92 | 0.768 to 0.973 | 0.9 | 0.732 to 0.965 |
ICC, intraclass correlation coefficient; RS, radial strain; CS, circumferential strain; LS, longitudinal strain.